What motivates gay and bisexual men to participate in PrEP-related research?
HIV
Pre-Exposure Prophylaxis (PrEP)
gay and bisexual men
qualitative data
recruitment
Journal
International journal of sexual health : official journal of the World Association for Sexual Health
ISSN: 1931-7611
Titre abrégé: Int J Sex Health
Pays: England
ID NLM: 101312593
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
1
9
2020
pubmed:
1
1
2019
medline:
1
1
2019
Statut:
ppublish
Résumé
Pre-Exposure Prophylaxis (PrEP) has been demonstrated effective at preventing HIV among key populations like gay and bisexual men (GBM). Yet, there remains a continued need to engage GBM in PrEP behavioral and clinical research (e.g., to monitor adherence and retention in the PrEP treatment cascade). We report on the factors motivating GBM to participate in a PrEP behavioral study, with the aim of our results to inform future recruitment efforts for future PrEP research. In 2015-2016, 103 PrEP-using GBM in NYC completed qualitative interviews about their experiences on PrEP. Participants were also asked about factors that motivated them to join the study. Thematic analysis was used analyze the data. We identified five salient themes as rationale for joining the study: 58.3% cited altruistic reasons, 32% reported intellectual curiosity in the subject matter, 30.1% indicated that remuneration inspired them, 18.4% indicated that familiarity or referral to the research institute influenced their decision. Researchers attempting to enroll PrEP-using GBM may benefit from attending to the altruistic and intellectually curious nature of this population. Further, researchers may benefit from establishing familiarity among diverse communities of GBM. This in turn may contribute to the successful engagement of GBM for PrEP research.
Identifiants
pubmed: 32864033
doi: 10.1080/19317611.2019.1634173
pmc: PMC7454037
mid: NIHMS1534023
doi:
Types de publication
Journal Article
Langues
eng
Pagination
283-290Subventions
Organisme : NIDA NIH HHS
ID : R21 DA039019
Pays : United States
Déclaration de conflit d'intérêts
Conflict of Interest: All authors declare that they have no conflicts of interest.
Références
J Clin Epidemiol. 2007 Aug;60(8):757-65
pubmed: 17606170
AIDS Educ Prev. 2002 Jun;14(3 Suppl A):27-37
pubmed: 12092934
Soc Sci Med. 2001 Mar;52(5):797-808
pubmed: 11218181
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):210-7
pubmed: 16394854
Subst Use Misuse. 2009;44(13):1855-71
pubmed: 20001284
AIDS Educ Prev. 2018 Aug;30(4):275-286
pubmed: 30148670
Sex Transm Infect. 2019 Dec;95(8):626-628
pubmed: 30126949
AIDS Educ Prev. 2014 Feb;26(1):56-67
pubmed: 24450278
AIDS Behav. 2018 Apr;22(4):1184-1189
pubmed: 28913659
Int J Popul Res. 2013 Nov 21;2013:
pubmed: 24639900
BMC Med Ethics. 2013;14 Suppl 1:S4
pubmed: 24564948
Arch Intern Med. 2002 Nov 25;162(21):2458-63
pubmed: 12437405
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):15-20
pubmed: 27552158
J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):63-71
pubmed: 11176270
Nurs Sci Q. 2011 Apr;24(2):146-51
pubmed: 21471039
PLoS One. 2014 Feb 03;9(2):e87674
pubmed: 24498350
J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):77-83
pubmed: 25117930
J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):119-127
pubmed: 29084044
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
Am J Health Promot. 2014 Nov-Dec;29(2):e82-90
pubmed: 24432823
AIDS Behav. 2012 Aug;16(6):1411-9
pubmed: 22016329
J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):250-258
pubmed: 28708811
AIDS Behav. 2012 Feb;16(2):256-65
pubmed: 21390535